Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion 1Neoplasms 1

Interventions

vandetanib 2Thoracoscopy 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Tenecteplase 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Afatinib 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pleural Effusion × Tenecteplase × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡